What one share of United Therapeutics holds
Founded by our Chairperson and Chief Executive Officer, Martine Rothblatt, to find a cure for her daughter’s life-threatening rare disease, pulmonary arterial hypertension (PAH), United Therapeutics advances therapies for people living with serious diseases with unmet medical needs.
United Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $67.25 |
|---|---|
| Profit | $27.95 |
| Capex (buildings and equipment) | $12.62 |
| Free cash flow | $23.30 |
| Cash and investments | $89.12 |
| Book value | $149.97 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2008 | $6.15 | −$1.08 | $2.72 | −$3.60 | — | $12.12 |
| 2009 | $6.39 | $0.35 | $1.70 | $0.08 | — | $12.04 |
| 2010 | $9.96 | $1.78 | $0.31 | $3.24 | — | $15.36 |
| 2011 | $12.51 | $3.67 | $0.61 | $3.61 | — | $17.69 |
| 2012 | $17.19 | $5.71 | $2.10 | $3.97 | — | $21.61 |
| 2013 | $20.98 | $3.28 | $0.60 | $7.39 | — | $24.99 |
| 2014 | $23.77 | $6.27 | $0.87 | $5.68 | — | $26.38 |
| 2015 | $28.63 | $12.73 | $0.97 | $6.50 | — | $34.72 |
| 2016 | $34.16 | $15.25 | $0.81 | $12.94 | — | $43.09 |
| 2017 | $38.43 | $9.31 | $1.92 | $8.64 | — | $48.61 |
| 2018 | $37.00 | $13.39 | $4.19 | $13.50 | — | $63.98 |
| 2019 | $33.08 | −$2.39 | $1.91 | −$6.63 | — | $63.36 |
| 2020 | $33.26 | $11.54 | $1.33 | $15.61 | — | $76.28 |
| 2021 | $35.63 | $10.06 | $2.55 | $10.09 | — | $87.77 |
| 2022 | $39.92 | $15.00 | $2.86 | $13.68 | — | $104.20 |
| 2023 | $46.83 | $19.81 | $4.64 | $15.04 | — | $127.23 |
| 2024 | $59.33 | $24.64 | $5.08 | $22.28 | — | $143.74 |
| 2025 | $66.44 | $27.86 | $10.87 | $21.73 | — | $162.60 |
Common questions about United Therapeutics
How much does one share of United Therapeutics earn?
Over the last 12 months, each share of United Therapeutics earned $27.95 of profit on $67.25 of sales, keeping about 42¢ of every $1 (profit margin).
Does United Therapeutics pay a dividend?
United Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is United Therapeutics’s book value per share?
United Therapeutics’s book value is $149.97 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of United Therapeutics have?
Each share of United Therapeutics has $89.12 of cash and investments, as of June 30, 2026.
What is United Therapeutics’s free cash flow per share?
$23.30 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has United Therapeutics bought back shares?
United Therapeutics’s share count rose about 5% from 2008 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.